We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
96 hedge funds and large institutions have $583M invested in Lexicon Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 35 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
170% more call options, than puts
Call options by funds: $1.3M | Put options by funds: $483K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
8% more capital invested
Capital invested by funds: $540M → $583M (+$43M)
2.38% more ownership
Funds ownership: 81.52% → 83.9% (+2.4%)
6% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 35
10% less funds holding
Funds holding: 107 → 96 (-11)
58% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 19
Holders
96
Holders Change
-11
Holders Change %
-10.28%
% of All Funds
1.68%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
8
Increased
33
Reduced
35
Closed
19
Calls
$1.3M
Puts
$483K
Net Calls
+$821K
Net Calls Change
-$656K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$24.5M |
| 2 |
EP
Eversept Partners
New York
|
+$2.64M |
| 3 |
IHAM
Integral Health Asset Management
New York
|
+$1.44M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.07M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$521K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4M |
| 2 |
BIG
Boothe Investment Group
Dover,
Delaware
|
-$2.04M |
| 3 |
Two Sigma Advisers
New York
|
-$1.65M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$1.58M |
| 5 |
Two Sigma Investments
New York
|
-$1.34M |
